The National Academies of Sciences, Engineering, and Medicine (NASEM) conducted an evaluation of the infant formula market and has made recommendations to Congress and national agencies about the vulnerabilities in the infant formula supply that need to be addressed to prevent future shortages like the 2022 crisis.
An expert report commissioned by the U.S. Food and Drug Administration (FDA) weighed the nutritional benefits of seafood consumption against the health risk of dietary exposure to contaminants in seafood, with special consideration to childhood growth and development.
NASEM has completed a study to better understand the nutritional benefits of seafood consumption versus the health hazards posed by contaminants like toxic heavy metals. The study fulfills a request from FDA, partly in a Closer to Zero effort to answer questions about mercury exposure. A webinar about the findings will be held on March 26, 2024.
The U.S. Food and Drug Administration (FDA) has announced that the National Academies of Sciences, Engineering, and Medicine (NASEM) will conduct an independent study on challenges in the U.S. infant formula supply, market competition, and regulation.
